ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
마이크로니들 인플루엔자 백신 시장 규모는 향후 몇 년 동안 빠르게 성장하여 2029년까지 10.4%의 CAGR로 24억 8,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장의 원동력은 전염병 대응 이니셔티브의 확대, 비침습적 백신 접종 방식에 대한 선호도 증가, 독감 이외의 질병에 대한 마이크로니들의 광범위한 적용, 환자 친화적인 백신 접종 옵션에 대한 수요 증가, 마이크로니들 패치의 제조 확장성 강화입니다. 이 기간의 주요 동향으로는 용해성 마이크로니들 기술로의 전환, 자가 투여 백신 모델에 대한 관심 증가, 마이크로니들과 웨어러블 건강 모니터링 시스템과의 통합, 마이크로니들 기반 인플루엔자 백신의 임상시험 증가, 소아 및 노인 인구에 대한 마이크로니들 플랫폼의 채택 등이 있습니다. 마이크로니들 플랫폼의 채택 등이 있습니다.
바늘 공포증의 유병률 증가는 마이크로 니들 인플루엔자 백신 시장의 성장을 촉진할 것으로 예상됩니다. 바늘 공포증은 바늘 공포증으로도 알려져 있으며, 바늘을 사용하는 시술의 광경, 감각 및 예상에 의해 유발되는 강한 두려움이나 불안으로, 종종 필요한 의료 개입을 피하도록 개인을 이끌 수 있습니다. 이 증상은 주로 심리적 과민 반응과 과거의 부정적인 경험에 의해 유발되어 장기적인 두려움과 회피 행동을 유발합니다. 마이크로 니들 인플루엔자 백신은 최소침습적이고 통증이 거의 없는 대안을 제공하여 백신 접종에 대한 심리적 장벽을 줄이고 환자의 순응도를 향상시키고 있습니다. 예를 들어, 2025년 2월 미국임상병리학회(ASCP)는 약 50-60%의 어린이가 주사바늘 공포증을 경험하고 있으며, 4-6세 사이에 공포증이 가장 만연하다고 보고했습니다. 그 결과, 주사바늘 공포증의 유병률 증가는 마이크로니들 인플루엔자 백신 시장의 확대에 기여하고 있습니다.
마이크로니들 인플루엔자 백신 시장의 주요 기업들은 패치형 RNA 백신 개발을 가속화하기 위한 투자 확보에 주력하고 있습니다. 이러한 노력은 초기 단계의 연구와 공동 연구를 지원하여 차세대 백신 전달 기술을 발전시키고 있습니다. 예를 들어, 2024년 3월 미국 정부 기관인 Biomedical Advanced Research and Development Authority(BARDA)는 독감 및 COVID-19를 표적으로 하는 마이크로니들 패치 기반 RNA 백신의 개발을 신속히 진행하기 위해 신속한 개발을 위해 Patch Forward Prize를 통해 5,000만 달러를 투자할 것이라고 발표했습니다. 이 이니셔티브는 개념 개발 자금을 지원하고, 조합 제품의 임상 1상 시험으로의 전환을 지원함으로써 기술 혁신을 촉진하는 것을 목표로 하고 있습니다. 이 프로그램은 백신 개발자와 패치 제조업체 간의 협력을 촉진하여 기술 및 규제 문제를 극복하고, 백신 접근성을 개선하며, 감염성 질환에 대한 국가적 대비를 강화하기 위한 목적으로 시행됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 마이크로니들 인플루엔자 백신 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 마이크로니들 인플루엔자 백신 시장 : 성장률 분석
세계의 마이크로니들 인플루엔자 백신 시장 실적 : 규모와 성장, 2019-2024년
세계의 마이크로니들 인플루엔자 백신 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 마이크로니들 인플루엔자 백신 전체 시장(TAM)
제6장 시장 세분화
세계의 마이크로니들 인플루엔자 백신 시장 : 제품 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
중공 마이크로니들
고체 마이크로니들
코팅 마이크로니들
용해 마이크로니들
세계의 마이크로니들 인플루엔자 백신 시장 : 투여 경로별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
경구
비경구
비강
세계의 마이크로니들 인플루엔자 백신 시장 : 유통 채널별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
병원 약국
소매 약국
온라인 약국
세계의 마이크로니들 인플루엔자 백신 시장 : 용도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
인플루엔자 예방 접종
계절성 인플루엔자 예방
소아 백신
노인용 백신
세계의 마이크로니들 인플루엔자 백신 시장, 중공 마이크로니들 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
일회용 중공 마이크로니들
다용 도중 하늘 마이크로니들
폴리머 기반 중공 마이크로니들
실리콘 기반 중공 마이크로니들
세계의 마이크로니들 인플루엔자 백신 시장, 고체 마이크로니들 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
금속 고체 마이크로니들
실리콘 고체 마이크로니들
폴리머 고체 마이크로니들
유리 고체 마이크로니들
세계의 마이크로니들 인플루엔자 백신 시장, 코팅 마이크로니들 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
약제 코팅 마이크로니들
백신 코팅 마이크로니들
생분해성 코팅 마이크로니들
나노코팅 마이크로니들
세계의 마이크로니들 인플루엔자 백신 시장, 용해 마이크로니들 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
속용성 마이크로니들
서방형 마이크로니들
하이드로겔 기반 용해 마이크로니들
당 기반 용해 마이크로니들
제7장 지역별·국가별 분석
세계의 마이크로니들 인플루엔자 백신 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 마이크로니들 인플루엔자 백신 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
마이크로니들 인플루엔자 백신 시장 : 경쟁 구도
마이크로니들 인플루엔자 백신 시장 : 기업 개요
Merck & Co. Inc.
Sanofi SA
AstraZeneca plc
Novartis AG
Becton Dickinson and Company(BD)
제31장 기타 주요 기업과 혁신적 기업
AptarGroup
Corium International
CosMED Pharmaceutical Co. Ltd.
Vaxxas
PharmaJet
Inovio Pharmaceuticals
Vaxess Technologies
FluGen Inc.
DebIoTech S.A.
Micron Biomedical Inc.
NanoPass Technologies Limited
Micropoint Technologies Pte Ltd.
TSRL Inc.
Verndari Inc.
Microdermics Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 전략
마이크로니들 인플루엔자 백신 시장, 2029년 : 새로운 기회를 제공하는 국가
마이크로니들 인플루엔자 백신 시장, 2029년 : 새로운 기회를 제공하는 부문
마이크로니들 인플루엔자 백신 시장, 2029년 : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
The microneedle flu vaccine is an innovative vaccination method that uses a small, patch-like array of microscopic needles to painlessly deliver the influenza vaccine into the skin. This approach offers a minimally invasive, efficient, and user-friendly alternative to traditional intramuscular injections. It is designed to enhance vaccine accessibility, increase patient compliance, facilitate self-administration, and improve immunization coverage, especially in large-scale public health initiatives.
The main product types of microneedle flu vaccines include hollow microneedles, solid microneedles, coated microneedles, and dissolving microneedles. A hollow microneedle is a micro-scale needle with a central lumen, allowing for the direct injection of liquid formulations into the skin. These vaccines can be administered through various routes, such as oral, parenteral, and nasal, and are distributed through several channels, including hospital pharmacies, retail pharmacies, and online pharmacies. Applications for these vaccines include flu vaccination, seasonal flu prevention, pediatric vaccines, and vaccines for the elderly.
The microneedle flu vaccine market research report is one of a series of new reports from The Business Research Company that provides microneedle flu vaccine market statistics, including microneedle flu vaccine industry global market size, regional shares, competitors with a microneedle flu vaccine market share, detailed microneedle flu vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the microneedle flu vaccine industry. This microneedle flu vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The microneedle flu vaccine market size has grown rapidly in recent years. It will grow from $1.51 billion in 2024 to $1.67 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth during the historic period can be attributed to the increasing global burden of seasonal influenza, rising awareness about the benefits of vaccination, government efforts to improve immunization coverage, a growing preference for minimally invasive drug delivery methods, and the early clinical success of microneedle vaccines in animal models.
The microneedle flu vaccine market size is expected to see rapid growth in the next few years. It will grow to $2.48 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The anticipated growth in the forecast period is driven by the expansion of pandemic preparedness initiatives, increasing preference for needle-free vaccination methods, broader application of microneedles for diseases beyond influenza, rising demand for patient-friendly vaccination options, and enhanced manufacturing scalability of microneedle patches. Key trends during this period include a shift toward dissolvable microneedle technologies, a growing focus on self-administered vaccine models, integration of microneedles with wearable health monitoring systems, a rise in clinical trials for microneedle-based influenza vaccines, and the adoption of microneedle platforms for pediatric and elderly populations.
The increasing prevalence of needle phobia is expected to drive the growth of the microneedle flu vaccine market. Needle phobia, also known as trypanophobia, is an intense fear or anxiety triggered by the sight, sensation, or anticipation of needle-based procedures, often leading individuals to avoid necessary medical interventions. This condition is primarily fueled by psychological sensitivity and negative past experiences, creating long-term fear and avoidance behavior. Microneedle flu vaccines provide a minimally invasive and nearly painless alternative, which reduces psychological barriers to vaccination and encourages better patient compliance. For example, in February 2025, the American Society for Clinical Pathology (ASCP) reported that approximately 50% to 60% of children experience needle phobia, with the fear being most prevalent between the ages of 4 and 6. As a result, the growing prevalence of needle phobia is contributing to the expansion of the microneedle flu vaccine market.
Leading companies in the microneedle flu vaccine market are focusing on securing investments to accelerate the development of patch-based RNA vaccines. These efforts support early-stage research and collaboration, advancing next-generation vaccine delivery technologies. For example, in March 2024, the Biomedical Advanced Research and Development Authority (BARDA), a U.S.-based government agency, announced a $50 million investment through the Patch Forward Prize to fast-track the development of microneedle patch-based RNA vaccines targeting influenza and COVID-19. This initiative aims to drive innovation by funding concept development and supporting the progression of combination products into Phase I clinical trials. The program fosters collaboration between vaccine developers and patch manufacturers, with the goal of overcoming technical and regulatory challenges, improving vaccine accessibility, and bolstering national preparedness for infectious diseases.
In January 2024, Gylden Pharma Limited (formerly Emergex Vaccines Holding Limited), a UK-based clinical-stage biotechnology company, partnered with DEKA Research & Development Corp. to enhance patient-friendly drug delivery through advanced microneedle-based intradermal administration technologies. The collaboration seeks to evaluate the compatibility and effectiveness of combining Emergex's immunotherapeutic candidates with DEKA's microneedle applicator for potential clinical use. DEKA Research & Development Corp., a U.S.-based company specializing in microneedle solutions, will play a pivotal role in advancing this technology.
Major players in the microneedle flu vaccine market are Merck & Co. Inc., Sanofi SA, AstraZeneca plc, Novartis AG, Becton Dickinson and Company (BD), AptarGroup, Corium International, CosMED Pharmaceutical Co. Ltd., Vaxxas, PharmaJet, Inovio Pharmaceuticals, Vaxess Technologies, FluGen Inc., Debiotech S.A., Micron Biomedical Inc., NanoPass Technologies Limited, Micropoint Technologies Pte Ltd., TSRL Inc., Verndari Inc., and Microdermics Inc.
North America was the largest region in the microneedle flu vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in microneedle flu vaccine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the microneedle flu vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The microneedle flu vaccine market consists of sales of polymer-based microneedle patches, hydrogel-forming microneedles, silicon microneedle arrays, biodegradable microneedle systems, metallic microneedles, and lipid-based microneedle formulations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Microneedle Flu Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on microneedle flu vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for microneedle flu vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The microneedle flu vaccine market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Microneedle Flu Vaccine Market Characteristics
3. Microneedle Flu Vaccine Market Trends And Strategies
4. Microneedle Flu Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Microneedle Flu Vaccine Growth Analysis And Strategic Analysis Framework
5.1. Global Microneedle Flu Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Microneedle Flu Vaccine Market Growth Rate Analysis
5.4. Global Microneedle Flu Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Microneedle Flu Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Microneedle Flu Vaccine Total Addressable Market (TAM)
6. Microneedle Flu Vaccine Market Segmentation
6.1. Global Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hollow Microneedle
Solid Microneedle
Coated Microneedle
Dissolving Microneedle
6.2. Global Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Nasal
6.3. Global Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.4. Global Microneedle Flu Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Flu Vaccination
Seasonal Flu Prevention
Pediatric Vaccines
Elderly Vaccines
6.5. Global Microneedle Flu Vaccine Market, Sub-Segmentation Of Hollow Microneedle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-Use Hollow Microneedles
Multiple-Use Hollow Microneedles
Polymer-Based Hollow Microneedles
Silicon-Based Hollow Microneedles
6.6. Global Microneedle Flu Vaccine Market, Sub-Segmentation Of Solid Microneedle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Metal Solid Microneedles
Silicon Solid Microneedles
Polymer Solid Microneedles
Glass Solid Microneedles
6.7. Global Microneedle Flu Vaccine Market, Sub-Segmentation Of Coated Microneedle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug-Coated Microneedles
Vaccine-Coated Microneedles
Biodegradable Coated Microneedles
Nano-Coated Microneedles
6.8. Global Microneedle Flu Vaccine Market, Sub-Segmentation Of Dissolving Microneedle, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fast-Dissolving Microneedles
Slow-Release Microneedles
Hydrogel-Based Dissolving Microneedles
Sugar-Based Dissolving Microneedles
7. Microneedle Flu Vaccine Market Regional And Country Analysis
7.1. Global Microneedle Flu Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Microneedle Flu Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Microneedle Flu Vaccine Market
9.1. China Microneedle Flu Vaccine Market Overview
9.2. China Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Microneedle Flu Vaccine Market
10.1. India Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Microneedle Flu Vaccine Market
11.1. Japan Microneedle Flu Vaccine Market Overview
11.2. Japan Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Microneedle Flu Vaccine Market
12.1. Australia Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Microneedle Flu Vaccine Market
13.1. Indonesia Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Microneedle Flu Vaccine Market
14.1. South Korea Microneedle Flu Vaccine Market Overview
14.2. South Korea Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Microneedle Flu Vaccine Market
15.1. Western Europe Microneedle Flu Vaccine Market Overview
15.2. Western Europe Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Microneedle Flu Vaccine Market
16.1. UK Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Microneedle Flu Vaccine Market
17.1. Germany Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Microneedle Flu Vaccine Market
18.1. France Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Microneedle Flu Vaccine Market
19.1. Italy Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Microneedle Flu Vaccine Market
20.1. Spain Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Microneedle Flu Vaccine Market
21.1. Eastern Europe Microneedle Flu Vaccine Market Overview
21.2. Eastern Europe Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Microneedle Flu Vaccine Market
22.1. Russia Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Microneedle Flu Vaccine Market
23.1. North America Microneedle Flu Vaccine Market Overview
23.2. North America Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Microneedle Flu Vaccine Market
24.1. USA Microneedle Flu Vaccine Market Overview
24.2. USA Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Microneedle Flu Vaccine Market
26.1. South America Microneedle Flu Vaccine Market Overview
26.2. South America Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Microneedle Flu Vaccine Market
27.1. Brazil Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Microneedle Flu Vaccine Market
28.1. Middle East Microneedle Flu Vaccine Market Overview
28.2. Middle East Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Microneedle Flu Vaccine Market
29.1. Africa Microneedle Flu Vaccine Market Overview
29.2. Africa Microneedle Flu Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Microneedle Flu Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Microneedle Flu Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Microneedle Flu Vaccine Market Competitive Landscape And Company Profiles
